Genetics and Genomics of SOST: Functional Analysis of Variants and Genomic Regulation in Osteoblasts
Open Access
- 6 January 2021
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (2), 489
- https://doi.org/10.3390/ijms22020489
Abstract
SOST encodes the sclerostin protein, which acts as a key extracellular inhibitor of the canonical Wnt pathway in bone, playing a crucial role in skeletal development and bone homeostasis. The objective of this work was to assess the functionality of two variants previously identified (the rare variant rs570754792 and the missense variant p.Val10Ile) and to investigate the physical interactors of the SOST proximal promoter region in bone cells. Through a promoter luciferase reporter assay we show that the minor allele of rs570754792, a variant located in the extended TATA box motif, displays a significant decrease in promoter activity. Likewise, through western blot studies of extracellular and intracellular sclerostin, we observe a reduced expression of the p.Val10Ile mutant protein. Finally, using a circular chromosome conformation capture assay (4C-seq) in 3 bone cell types (MSC, hFOB, Saos-2), we have detected physical interactions between the SOST proximal promoter and the ECR5 enhancer, several additional enhancers located between EVT4 and MEOX1 and a distant region containing exon 18 of DHX8. In conclusion, SOST presents functional regulatory and missense variants that affect its expression and displays physical contacts with far reaching genomic sequences, which may play a role in its regulation within bone cells.Funding Information
- Ministerio de Economía y Competitividad (SAF2016-75948-R, SAF2014-56562-R)
This publication has 62 references indexed in Scilit:
- Disruption of Lrp4 function by genetic deletion or pharmacological blockade increases bone mass and serum sclerostin levelsProceedings of the National Academy of Sciences of the United States of America, 2014
- Members of the DAN Family Are BMP Antagonists That Form Highly Stable Noncovalent DimersJournal of Molecular Biology, 2012
- Wnt Antagonists Bind through a Short Peptide to the First β-Propeller Domain of LRP5/6Structure, 2011
- Bone Overgrowth-associated Mutations in the LRP4 Gene Impair Sclerostin Facilitator FunctionOnline Journal of Public Health Informatics, 2011
- Identification of signal peptide domain SOST mutations in autosomal dominant craniodiaphyseal dysplasiaHuman Genetics, 2011
- Lrp4, a Novel Receptor for Dickkopf 1 and Sclerostin, Is Expressed by Osteoblasts and Regulates Bone Growth and Turnover In VivoPLOS ONE, 2009
- Characterization of the Structural Features and Interactions of SclerostinJournal of Biological Chemistry, 2009
- SOST Is a Ligand for LRP5/LRP6 and a Wnt Signaling InhibitorOnline Journal of Public Health Informatics, 2005
- Sclerostin Binds to LRP5/6 and Antagonizes Canonical Wnt SignalingOnline Journal of Public Health Informatics, 2005
- Dominantly inherited craniodiaphyseal dysplasia: A new craniotubular dysplasiaClinical Genetics, 1986